People who take GLP-1 medications for weight loss or diabetes may be exercising less, according to a report presented at the Endocrine Society. The findings suggest that while these drugs can help reduce body weight, patients might become less physically active during treatment. Experts urge healthcare providers to consider exercise counseling as part of a comprehensive care plan.

Key Takeaways

  • A study presented at the Endocrine Society found that GLP-1 drug users showed a decline in physical activity levels.
  • The drop in exercise could undermine some of the long-term health benefits associated with weight loss.
  • Healthcare professionals are encouraged to actively promote exercise alongside GLP-1 therapy.

What the Report Found

The report, released by the Endocrine Society, examined physical activity patterns among individuals taking GLP-1 receptor agonists such as semaglutide and liraglutide. According to the findings, patients reported engaging in less exercise after starting these medications compared to their activity levels before treatment. The exact reasons for the decline were not detailed in the report, but researchers speculate that side effects such as nausea, fatigue, or a reduced appetite for movement may play a role. The data underscore a potential gap in current weight management strategies that focus heavily on drug efficacy without addressing lifestyle changes.

Why Exercise Matters for People on GLP-1 Drugs

Exercise is a cornerstone of metabolic health. It helps preserve lean muscle mass, improves insulin sensitivity, and supports cardiovascular function. When patients lose weight solely through medication, they may also lose muscle tissue. Regular physical activity can counteract muscle loss and enhance the overall metabolic benefits of weight reduction. The Endocrine Society report suggests that if exercise declines, patients may not achieve the full range of health improvements they could gain from combining drug therapy with an active lifestyle. For individuals with type 2 diabetes, exercise also helps control blood sugar levels, which is particularly important when using GLP-1 drugs that already affect glucose regulation.

How to Maintain Physical Activity While Taking GLP-1 Medications

Patients and clinicians can work together to keep exercise levels stable. Strategies include starting with low intensity activities such as walking or stretching to manage potential fatigue or nausea. Setting small, achievable goals and gradually increasing duration can help build consistency. Some patients may benefit from working with a physical therapist or exercise specialist who understands the side effects of GLP-1 drugs. The report emphasizes that exercise should be viewed as a necessary complement to medication, not an afterthought. Regular check ins with a healthcare provider can help adjust exercise plans as treatment progresses.

Frequently Asked Questions

Does every person taking a GLP-1 drug exercise less?

No. The Endocrine Society report describes a general trend observed in the study population. Individual experiences vary. Some people may maintain or even increase their activity levels, especially if they receive counseling or have prior exercise habits. The findings highlight the need for personalized support.

Can exercise reduce the side effects of GLP 1 medications?

Moderate exercise may help manage some side effects. For example, gentle movement can ease bloating or improve digestion. However, intense exercise might worsen nausea or fatigue in some individuals. It is best to consult a doctor before starting or adjusting an exercise routine while on GLP 1 therapy.

Should I stop my GLP 1 medication if I cannot exercise much?

No. Never stop a prescribed medication without discussing it with your healthcare provider. The weight and metabolic benefits of GLP-1 drugs are well established. If you find it difficult to stay active, talk to your doctor about ways to incorporate gentle exercise or refer you to a specialist. The drug and exercise should work together, not be considered a trade off.

This is an original report by Vital Signs Today, informed by reporting from Google News. Read the original source.

This article is for information only and is not medical advice. See our Medical Disclaimer.